NeoStemNeoStem Achieves New Milestone as Company Joins Russell 3000 IndexNeoStem, Inc. announces it has been added to the broad-market Russell 3000 Index with Russell Investments’ reconstitution of its comprehensive set of U.S. and global equity indexes effective June 25th. NeoStem Provides Business UpdateNeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China, announces a number of business updates. NeoStem Inc: Expanding Stem Cell Technology into ChinaNeoStem, Inc (AMEX: NBS) NeoStem Chinese Subsidiary Receives OK from China SFDA to Manufacture PenicilinNeoStem, Inc. announces it was advised that its Suzhou Erye Pharmaceutical subsidiary (“Erye”) received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin. |
|
Standard Podcast [12:25m]: 
WSR Recommends |
||
| Special Deal for Our Readers (That’s You!) | Jim Cramer: The Clown That Makes You Money | Get Rich with Fibonacci. Learn How to Use Fibonacci Analysis to Trade Better. |
